phenytoin has been researched along with Hepatolenticular Degeneration in 2 studies
Hepatolenticular Degeneration: A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pakszys, W | 1 |
| Ligezińska, B | 1 |
| Szymański, H | 1 |
| Lössner, J | 1 |
| Kühn, HJ | 1 |
2 other studies available for phenytoin and Hepatolenticular Degeneration
| Article | Year |
|---|---|
[Test of stimulation of ceruloplasmin activity and copper concentration as affected by diphenylhydantoin (phenytoin, TSC) in the diagnosis of hepatolenticular degeneration].
Topics: Adult; Ceruloplasmin; Copper; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Phenytoin; S | 1982 |
[Diphenylhydantoin stimulation test in Wilson's disease].
Topics: Adult; Ceruloplasmin; Epilepsy; Female; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Ph | 1979 |